Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.68 |
| ▸ | TP53 | P04637 | 3/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
| ▸ | HTR2B | P41595 | 1/20 | 0.68 |
| ▸ | RAB9A | P51151 | 7/20 | 0.64 |
| ▸ | NPC1 | O15118 | 6/20 | 0.64 |
| ▸ | MEN1 | O00255 | 5/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.64 |
| ▸ | GAA | P10253 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | MAOA | P21397 | 1/20 | 0.58 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.58 |
| ▸ | GSK3B | P49841 | 1/20 | 0.51 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluindione SCHEMBL29362659 | 1.00 | MAPT (0.68) | MAPTTP53LMNACYP1A2CYP3A4 | |
| Phenindione SCHEMBL33831 | 0.81 | MAPT (1.00) | MAPTTP53LMNACYP1A2CYP3A4 | |
| Phenindione SCHEMBL29388073 | 0.81 | MAPT (1.00) | MAPTTP53LMNACYP1A2CYP3A4 | |
| SCHEMBL14940294 | 0.81 | MAPT (0.59) | MAPTTP53LMNACYP1A2CYP3A4 | |
| SCHEMBL17525348 | 0.80 | MAPT (0.71) | MAPTTP53LMNACYP1A2CYP3A4 | |
| SCHEMBL10559114 | 0.79 | MAPT (0.95) | MAPTTP53LMNACYP1A2CYP3A4 | |
| Phenindione SCHEMBL1443973 | 0.79 | MAPT (0.95) | MAPTTP53LMNACYP1A2CYP3A4 | |
| Phenindione SCHEMBL6827577 | 0.79 | MAPT (0.95) | MAPTTP53LMNACYP1A2CYP3A4 | |
| Clorindione SCHEMBL43305 | 0.78 | RAB9A (1.00) | MAPTTP53LMNACYP1A2CYP3A4 | |
| SCHEMBL10559578 | 0.78 | MEN1 (1.00) | MAPTTP53LMNACYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 739 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250333462-A1 | PERIOSTIN COMPOUNDS FOR THE TREATMENT OF HAEMATOLOGICAL COMPLICATIONS | CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG-SPEYER-HAUS (DE) | 2025-10-30 | — | — | US | claimed |
| EP-3823660-B1 | PERIOSTIN COMPOUNDS FOR THE TREATMENT OF HAEMATOLOGICAL COMPLICATIONS | UNIV DER JOHANNES GUTENBERG UNIV MAINZ (DE) | 2025-05-07 | — | — | EP | claimed |
| US-20240304334-A1 | CLOTTABILITY-BASED PERSONALIZED TREATMENT (CPT) SYSTEM | PUN SAN (CH) | 2024-09-12 | — | — | US | claimed |
| EP-4337965-A1 | CLOTTABILITY-BASED PERSONALIZED TREATMENT (CPT) SYSTEM | Pun, San (CH) | 2024-03-20 | — | — | EP | claimed |
| US-20240066065-A1 | PLATELET DERIVATIVES FOR TREATING COAGULOPATHY | CELLPHIRE, INC. (US) | 2024-02-29 | — | — | US | claimed |
| WO-2023275213-A1 | CLOTTABILITY-BASED PERSONALIZED TREATMENT (CPT) SYSTEM | PUN SAN (CH) | 2023-01-05 | — | — | WO | claimed |
| US-20220279777-A1 | FREEZE-DRIED PLATELET DERIVATIVE COMPOSITIONS FOR TREATING ANTICOAGULANT-INDUCED COAGULOPATHY | CELLPHIRE INC. (US) | 2022-09-08 | — | — | US | claimed |
| WO-2022178191-A1 | FREEZE-DRIED PLATELET DERIVATIVE COMPOSITIONS FOR TREATING ANTICOAGULANT-INDUCED COAGULOPATHY | CELLPHIRE, INC. (US) | 2022-08-25 | — | — | WO | claimed |
| EP-4013432-A1 | THROMBOSOMES AS AN ANTICOAGULANT REVERSAL AGENT | Cellphire Inc. (US) | 2022-06-22 | — | — | EP | claimed |
| US-11318331-B2 | Pulmonary hypertension treatment | SONIVIE LTD. (IL) | 2022-05-03 | — | — | US | claimed |
| US-20060286614-A1 | METHOD FOR MONITORING COAGULABILITY AND HYPERCOAGULABLE STATES | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 2006-12-21 | — | — | US | claimed |
| US-20040127996-A1 | Delivering an agent to a patient's body | BOSTON SCIENTIFIC SCIMED, INC. | 2004-07-01 | — | — | US | claimed |
| EP-1408949-A2 | GLYCINE BETAINE AND ITS USE AS ANTI-HEMORRHAGIC AGENT | Messadek, Jallal (BE) | 2004-04-21 | — | — | EP | claimed |
| US-20040033223-A1 | Glycine betaine and its use | MESSADEK JALLAL (BE) | 2004-02-19 | — | — | US | claimed |
| EP-1387649-A1 | DELIVERING AN AGENT TO A PATIENT'S BODY | SciMed Life Systems, Inc. (US) | 2004-02-11 | — | — | EP | claimed |
| EP-1368661-A2 | MONITORING SOLUABLE ENDOTHELIAL PROTEIN C RECEPTOR LEVELS IN ANTICOAGULANT THERAPY | Oklahoma Medical Research Foundation (US) | 2003-12-10 | — | — | EP | claimed |
| US-20020173818-A1 | Delivering an agent to a patient's body | BOSTON SCIENTIFIC SCIMED, INC. | 2002-11-21 | — | — | US | claimed |
| WO-2002091957-A1 | DELIVERING AN AGENT TO A PATIENT'S BODY | SCIMED LIFE SYSTEM, INC. (US) | 2002-11-21 | — | — | WO | claimed |
| WO-2002066981-A2 | MONITORING SOLUBLE ENDOTHELIAL PROTEIN C RECEPTOR LEVELS IN ANTICOAGULANT THERAPY | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 2002-08-29 | — | — | WO | claimed |
| WO-2002062322-A2 | GLYCINE BETAINE AND ITS USE AS ANTI-HEMORRHAGIC AGENT | MESSADEK JALLAL (BE) | 2002-08-15 | — | — | WO | claimed |